Your shopping cart is currently empty

Liothyronine sodium hydrate (Triiodothyronine sodium hydrate) is a TRα and TRβ agonist and a thyroxine analog with anticancer and antitumor activities. It can be used to study hypothyroidism, stroke and cognitive dysfunction.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 mg | $35 | - | In Stock |
| Description | Liothyronine sodium hydrate (Triiodothyronine sodium hydrate) is a TRα and TRβ agonist and a thyroxine analog with anticancer and antitumor activities. It can be used to study hypothyroidism, stroke and cognitive dysfunction. |
| Targets&IC50 | TRβ (human):2.33 nM, TRα (human):2.33 nM |
| In vitro | b>METHODS: Liothyronine sodium hydrate (100 μM, 3 weeks) was used to treat liver cancer cells (Mahlavu, SK-Hep-1, J5, 5328 and HepG2) and the cell growth was observed. RESULTS: Liothyronine sodium hydrate can stimulate the proliferation of liver cancer cells. [1] |
| Synonyms | Triiodothyronine sodium hydrate, T3 sodium hydrate, 3,3',5-Triiodo-L-thyronine sodium hydrate |
| Formula | C15H11NNaO4 xH2O |
| Cas No. | 345957-19-9 |
| Smiles | IC(C=C(C=C1I)C[C@H](N)C([O-])=O)=C1OC2=CC(I)=C(C=C2)O.[Na+].O xH2O |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.